Announcements

ReACH Director, Dr. Barbara J. Turner featured on Texas Public Radio's Texas Standard

On Friday, March 31st, Dr. Barbara J. Turner, the Director of the Center for Research to Advance Community Health (ReACH) will be featured on the Texas Public Radio show Texas Standard to discuss a recently published study that looks at how much the Hispanic community knows about chronic pain.  Dr. Turner and her team conducted a population-based survey representing 8.8 million Hispanic residents of five Southwestern states who did not have chronic pain.  The data from this study reveal serious gaps in knowledge about chronic pain including misunderstanding about relying on narcotics to treat the disease. This is the first study to reveal poor knowledge about chronic pain in a large population of Americans and reinforces the urgency of launching a broad-based educational campaign about chronic pain and its care. 
 
 

ReACH Scholar Bertha "Penny" Flores, PhD, APRN, WHNP-BC Selected for the National Hispanic Health Foundation (NHHF) PCORI Hispanic Patient-Centered Health Research Mentorship Program

ReACH Scholar Bertha "Penny" Flores, PhD, APRN, WHNP-BC was recently selected for the the National Hispanic Health Foundation (NHHF) PCORI Hispanic Patient-Centered Health Research Mentorship Program. This unique mentorship and training program provides individualized mentoring by Hispanic senior faculty researchers, networking with PCOR experts and other researchers in Hispanic health equity, skills building for career development, a two day in-person PCOR training with a special session to present your research.  Congratulations Dr. Flores!

Bertha "Penny" Flores PhD, APRN, WHNP-BC Awarded KL2 Grant

We are pleased to announce that ReACH Scholar,  Penny Flores PhD, APRN, WHNP-BC  has been awarded a KL2 grant.  Congratulations on this exciting achievement Dr. Flores! 

 

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

Barbara J. Turner, MD, MSED, MACP

Barbara Turner
Contact: 

Barbara J Turner MD, MSED
Director, REACH Center
Professor of Medicine, UTHSCSA
Adjunct Professor, UTSPH
Director, Health Outcomes Research, UHS

7411 John Smith, Suite 1050
San Antonio, TX 78229
Phone:  (210) 562-5550
Fax: (210) 562-5560
email: turner@uthscsa.edu

Director

Barbara J Turner MD, MSED, MACP is James D. and Ona I. Dye Professor of Medicine at the University of Texas Health Science Center San Antonio and the founding director of the Center for Research to Advance Community Health (ReACH). She was formerly the Executive Deputy Editor of the Annals of Internal Medicine and a Professor of Medicine at the University of Pennsylvania. Dr. Turner is a practicing general internist and health services researcher focusing on vulnerable populations and health disparities using administrative databases to evaluate care. Dr. Turner has over 140 peer-reviewed publications and editorials on: quality of ambulatory care; cardiovascular and cancer preventive care; HIV care; chronic pain/opioid use; substance abuse; primary care practice redesign; and patient adherence to care. She has directed several randomized clinical trials that use peer coaches to improve receipt of needed cancer preventive services and to reduce cardiovascular risk in high risk African-Americans. She was formerly the Director of the Primary Care NRSA Fellowship at the University of Pennsylvania School of Medicine. Dr Turner has served as Regent of the American College of Physicians (ACP) and President of the Society of General Internal Medicine (SGIM). She was also Chair of HRSA’s Advisory Committee on Training in Primary Care Medicine and Dentistry. She has received grants from the National Institute on Drug Abuse, the Agency for Health Care Research and Quality, the Robert Wood Johnson Foundation, the Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, the Center for Substance Abuse Treatment, among others.

Research Interests: 

Health disparities, quality of care, cardiovascular disease, cancer prevention and substance abuse.